Merck said a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its treatment.
Russia changes nuclear doctrine as Ukraine gets OK to use U.S. long-range weapons
Moscow will now consider a conventional attack on Russia by any nation supported by a nuclear power to be a joint attack, according to a change in the country’s nuclear…